IGF2BP1 is recurrently involved in fusions with IGH@ in BCP ALL and has previously been reported to be highly expressed in ETV6/RUNX1-positive cases22,23. The gene discussed is IGF2BP1; the disease is acute lymphoblastic leukemia.